Gene Expression of CXCL1 (GRO-α) and EGF by Platelets in Myeloproliferative Neoplasms
暂无分享,去创建一个
[1] H. Hasselbalch. Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs? , 2020, HemaSphere.
[2] P. Campbell,et al. Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia , 2020, HemaSphere.
[3] Belinda B. Guo,et al. Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis , 2020, British journal of haematology.
[4] T. McIntyre,et al. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor–Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition , 2018, The Journal of Immunology.
[5] W. Talloen,et al. Plasma levels of growth‐related oncogene (CXCL1‐3) associated with fibrosis and platelet counts in HCV‐infected patients , 2015, Alimentary pharmacology & therapeutics.
[6] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[7] N. Villamor,et al. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. , 2006, Haematologica.
[8] T. Barbui,et al. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. , 2005, Experimental hematology.
[9] M. Jensen,et al. Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders , 2000, British journal of haematology.
[10] M. Rothenberg,et al. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. , 1999, American journal of respiratory cell and molecular biology.